Touchstone
Last syncNov 1, 2026, 6:55 PM ET

MEDP

Medpace Holdings, Inc. Health Care Services-Commercial Physical & Biological Research Russell 3000
$652.01Close $18.5BMarket cap $393.42 – $692.6852-week range Mid-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Earnings growing EPS +26% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 22, 2026
Off 12-month high 6%
1wk down 2.6% price change
1mo up 4.5% price change
12-month return up 12% market up 11% · its own up 1%
F-score — — Not assessed
Altman Z″ 0.20 Low riskadjusted
P/E 41.0× price / earnings
PEG 1.96 P/E / EPS growth
P/B 40.3× price / book
Earnings yield up 3.0% EBIT / enterprise value
Cheaper than 34% of the market · expensive
Revenue growth up 20% year on year
EPS growth up 26% latest quarter · -12 pts
Sales growth up 9% latest quarter · -9 pts
ROE up 70% return on equity
Free cash margin up 27% $681.9M FCF
D/E — long-term debt / equity
Net debt / EBITDA -0.9× net cash
Interest cover —EBIT / interest

Trade setup

ATR% 3.3% $21.41 a day · 2×ATR $609.19
RS 78 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.8× vs 50-day average
Up/down volume 1.11 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 21, 2026
Results reaction Oct 21, 2026+6% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.5B +20% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $925.9M FY2021 · $1.1B FY2022 · $1.5B FY2023 · $1.9B FY2024 · $2.1B FY2025 · $2.5B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $451.1M +12% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $145.4M FY2021 · $181.8M FY2022 · $245.4M FY2023 · $282.8M FY2024 · $404.4M FY2025 · $451.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $681.9M +19% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $227.3M FY2021 · $235.1M FY2022 · $351.2M FY2023 · $396.7M FY2024 · $572.3M FY2025 · $681.9M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 18%
  • Free cash 27%
0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 16% · Free cash 25% FY2021 · Net 16% · Free cash 21% FY2022 · Net 17% · Free cash 24% FY2023 · Net 15% · Free cash 21% FY2024 · Net 19% · Free cash 27% FY2025 · Net 18% · Free cash 27%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $277.8M FY2021 · Cash $461.3M FY2022 · Cash $28.3M FY2023 · Cash $245.4M FY2024 · Cash $669.4M FY2025 · Cash $497.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 28.37m -20.1% since FY2020
36.01m 28.37m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 35.52m FY2021 · 36.01m FY2022 · 31.09m FY2023 · 30.75m FY2024 · 30.63m FY2025 · 28.37m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $925.9M $1.1B $1.5B $1.9B $2.1B $2.5B
Operating income $167.0M $198.6M $278.7M $336.8M $446.9M $534.9M
Net income $145.4M $181.8M $245.4M $282.8M $404.4M $451.1M
Net margin 16% 16% 17% 15% 19% 18%
Earnings per share $3.86 $4.82 $7.29 $8.88 $12.63 $15.28
Free cash flow $227.3M $235.1M $351.2M $396.7M $572.3M $681.9M
Free cash margin 25% 21% 24% 21% 27% 27%
Cash $277.8M $461.3M $28.3M $245.4M $669.4M $497.0M
Shareholders' equity $805.8M $952.9M $386.4M $559.0M $825.5M $459.1M
Shares outstanding 35.52m 36.01m 31.09m 30.75m 30.63m 28.37m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 22, 2026 Quarterly ↗ Sep 30, 2026 22d
Jul 23, 2026 Quarterly ↗ Jun 30, 2026 23d
Apr 23, 2026 Quarterly ↗ Mar 31, 2026 23d
Feb 10, 2026 Annual ↗ Dec 31, 2025 41d
Oct 23, 2025 Quarterly ↗ Sep 30, 2025 23d
Jul 22, 2025 Quarterly ↗ Jun 30, 2025 22d
Apr 22, 2025 Quarterly ↗ Mar 31, 2025 22d
Feb 11, 2025 Annual ↗ Dec 31, 2024 42d
Oct 22, 2024 Quarterly ↗ Sep 30, 2024 22d
Jul 23, 2024 Quarterly ↗ Jun 30, 2024 23d
Apr 23, 2024 Quarterly ↗ Mar 31, 2024 23d
Feb 13, 2024 Annual ↗ Dec 31, 2023 44d

Current reports

FiledDisclosed
Oct 21, 2026 Results · Other events ↗
Jul 22, 2026 Results ↗
Jun 4, 2026 Director or officer change ↗
May 19, 2026 Charter or bylaws · Shareholder vote ↗
Apr 22, 2026 Results · Director or officer change ↗
Feb 9, 2026 Results ↗
Oct 22, 2025 Results ↗
Jul 21, 2025 Material agreement · Results ↗
May 16, 2025 Director or officer change · Shareholder vote ↗
Apr 21, 2025 Material agreement · Results · Other events ↗
Mar 31, 2025 Material agreement ↗
Feb 10, 2025 Results · Other events ↗